Peer-reviewed veterinary case report
Canine atopic dermatitis: Role of luteolin as new natural treatment
- Journal:
- Veterinary Medicine and Science
- Year:
- 2020
- Authors:
- Gugliandolo, Enrico et al.
- Affiliation:
- Department of Chemical Biological, Pharmaceutical and Environmental Sciences University of Messina Messina Italy · Italy
- Species:
- dog
Abstract
AbstractBackgroundLuteolin has been demonstrated to possess numerous biological effects. However, the effect of luteolin on LPS (Lipopolysaccharides) stimulation in CPEK cells has not been investigated.Hypothesis/ObjectivesAn in vitro model of atopic canine dermatitis was used to identify the antioxidant effect of luteolin as a new treatment that is capable of improving the conditions of veterinary patients.MethodsCPEK cells were treated with or without luteolin in the presence or absence of LPS. A cell viability assay was performed to test luteolin toxicity and the protective effect of luteolin after LPS stimulation. Additionally, enzyme‐linked immunosorbent assay (ELISA) kits were used to detect the levels of IL‐33, IL‐1β, IL‐6, and IL‐8.ResultsLuteolin was capable to significantly decrease levels expression of IL‐33, IL 1β, IL‐6, and IL‐8.Conclusions and clinical importanceLuteolin could be a new pharmacological treatment for canine atopic dermatitis.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://doi.org/10.1002/vms3.325